Abstract
Cardiovascular diseases represent the leading cause of morbidity and mortality, worldwide. Early detection and appropriate management of cardiovascular risk factors and disease markers in daily clinical practice may improve preventive strategies and reduce the burden of cardiovascular disease.
The EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation) programme was an educational programme aimed at evaluating prevalence of major cardiovascular risk factors among outpatients, and preferences and attitudes for cardiovascular disease management among Italian physicians in their routine clinical practice.
This article provides an overview of the main findings of different analyses from the EFFECTUS database, which have demonstrated a high prevalence of cardiovascular risk factors, irrespective of the clinical settings and outpatient clinics in which patients were followed. Also, findings from this database suggest that more intensive clinical data recording was paralleled by better adherence to guidelines, and that use of electronic rather than conventional support for clinical data collection and registration improved accuracy in data recording, which translated into better management of patients at risk in daily clinical practice.
Similar content being viewed by others
References
Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17; 364(9438): 953–62
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep 11-17; 364(9438): 937–52
Mendis S, Lindholm LH, Mancia G, et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007 Aug; 25(8): 1578–82
Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009 Apr; 16(2): 121–37
Manuel DG, Lim J, Tanuseputro P, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006 Mar 18; 332(7542): 659–62
Volpe M, Tocci G. Managing hypertension in cardiology practice according to risk profile. Int J Clin Pract 2008 Sep; 62(9): 1403–12
Volpe M, Machado E. Treatment priorities and current prescribing patterns in hypertension: results of GRASP, an international physician survey. Curr Med Res Opin 2004 Jul; 20(7): 1151–60
Tocci G, Giovannelli F, Sciarretta S, et al. Management of hypertension and stroke prevention: results of the Italian cardiologist survey. Int J Clin Pract 2009 Feb; 63(2): 207–16
Volpe M, Tocci G, Trimarco B, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007 Jul; 25(7): 1491–8
Volpe M, Tocci G, Avogaro A, et al. Global Cardiovascular Risk Assessment in Different Clinical Settings: Basal Results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) programme. High Blood Press Cardiovasc Prev 2009; 16(2): 55–63
Tocci G, Ferrucci A, Guida P, et al. Global cardiovascular risk management in different Italian regions: an analysis of the evaluation of final feasible effect of control training and ultra sensitisation (EFFECTUS) educational program. Nutr Metab Cardiovasc Dis. Epub 2010 Dec 24
Tocci G, Ferrucci A, Guida P, et al. Use of electronic support for implementing global cardiovascular risk management: analysis of the results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra Sensitisation) educational programme. High Blood Press Cardiovasc Prev 2010; 17(1): 37–47
Giorda CB, Guida P, Avogaro A, et al. Association of physicians’ accuracy in recording with quality of care in cardiovascular medicine. Eur J Cardiovasc Prev Rehabil 2009 Dec; 16(6): 722–8
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007 Jun; 25(6): 1105–87
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 May 16; 285 (19): 2486-97
Sesti G, Volpe M, Cosentino F, et al. Metabolic syndrome: diagnosis and clinical management, an official document of the Working Group of the Italian Society of Cardiovascular Prevention (SIPREC). High Blood Press Cardiovasc Prev 2006; 13(4): 185–98
Grundy SM, Brewer Jr HB, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 Jan 27; 109(3): 433–8
Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007 Jan; 28(1): 88–136
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010 Jan; 33 Suppl. 1: S62-9
Volpe M, Borghi C, Cavallo Perin P, et al. Cardiovascular prevention in subjects with impaired fasting glucose or impaired glucose tolerance. High Blood Press Cardiovasc Prev 2010; 17(2): 73–102
Leoncini G, Viazzi F, Rosei EA, et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010 Jan; 28(1): 156–62
Bramlage P, Bohm M, Volpe M, et al. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich) 2010 Sep; 12(9): 666–77
Palmieri L, Panico S, Vanuzzo D, et al. Evaluation of the global cardiovascular absolute risk: the Progetto CUORE individual score. Ann Ist Super Sanita 2004; 40(4): 393–9
Acknowledgements
The authors wish to thank the 1078 Italian physicians for their contribution to this project (see appendix in Supplemental Digital Content 1, http://links.adisonline.com/HBZ/A1). This work has been supported by an unconditioned educational grant by Merck Sharp & Dohme, Italy, for data collection and analysis. The authors have been supported by a grant funding from Merck Sharp & Dohme, Italy.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Tocci, G., Ferrucci, A., Guida, P. et al. An Analysis of the Management of Cardiovascular Risk Factors in Routine Clinical Practice in Italy. High Blood Press Cardiovasc Prev 18, 19–30 (2011). https://doi.org/10.2165/11588040-000000000-00000
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2165/11588040-000000000-00000